drugset / Trial / NCT01144949
Study of Silodosin to Facilitate Passage of Urinary Stones
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess if patients treated with silodosin will have a higher spontaneous passage rate of their ureteral stone than those treated with placebo.
Timeline
- Start
- 2010-06
- Primary completion
- 2012-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Silodosin | Unknown | 8 mg | Oral |